Pablo
Irimia Sieira
Consultor Médico
Hospital Universitario Virgen Macarena
Sevilla, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario Virgen Macarena (10)
2024
-
Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
Frontiers in Neurology , Vol. 15
-
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937
2023
-
Recomendaciones de consenso para el tratamiento de la prevención de la migraña
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. 246-253
-
[Translated article] Consensus recommendations on the preventive treatment of migraine
Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. T246-T253
2022
-
Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Neurologia, Vol. 37, Núm. 5, pp. 390-402
2021
-
MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention
Journal of Headache and Pain, Vol. 22, Núm. 1
-
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
Neurologia, Vol. 36, Núm. 8, pp. 611-617
2020
-
Evaluation of the concomitant use of oral preventive treatments and onabotulinumtoxinA in chronic migraine: the PREVENBOX study
European Journal of Neurology, Vol. 27, Núm. 10, pp. 2102-2108
-
Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
Neurologia, Vol. 35, Núm. 8, pp. 568-578
2019
-
Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice
Neurologia, Vol. 34, Núm. 6, pp. 408-417